Medical Strategy is one of the leading independent healthcare investment advisers in Europe. In line with its core competence, the company focuses exclusively on managing and advising equity portfolios in the healthcare sector.

Company profile: download here

In 2018, Medical Strategy was awarded with the Finance Research AWARD. In the segment of Independent Asset Managers in Germany, the company was rated as “Outstanding“.

At the “Funds Europe Awards” in London in November 2018, Medical Strategy received a special commendation in the category “European Specialist Investment Firm of the Year”

2018:

 

20172017
20162015
Urkunde_III_GM_2015_DrMichaelFischer_de